Seranova Bio

New Haven, United States

Seranova Bio develops companion diagnostics or therapeutics to treat autoimmune disease or other autoantibody-driven diseases.

$10.0M raised

Feb 2024

Venture - Series Unknown

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Seranova Bio

How much funding has Seranova Bio raised?

Seranova Bio has raised $10.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2024.

Where is Seranova Bio headquartered?

Seranova Bio is headquartered in New Haven, United States.

What does Seranova Bio do?

Seranova Bio develops companion diagnostics or therapeutics to treat autoimmune disease or other autoantibody-driven diseases.

What stage is Seranova Bio at?

Seranova Bio is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 4, 2024.

MLA

"Seranova Bio — Funding & Investors." VCBacked, February 4, 2024, https://www.vcbacked.co/company/seranova-bio. Accessed July 2, 2026.

APA

VCBacked. (2024). Seranova Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/seranova-bio

Wikipedia (cite web)

{{cite web |title=Seranova Bio — Funding & Investors |url=https://www.vcbacked.co/company/seranova-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 4, 2024.